4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      [A new treatment of keratectasia after LASIK by using collagen with riboflavin/UVA light cross-linking].

      Klinische Monatsblätter für Augenheilkunde
      Adult, Collagen, drug effects, radiation effects, Corneal Diseases, diagnosis, etiology, prevention & control, Corneal Topography, Cross-Linking Reagents, therapeutic use, Dilatation, Pathologic, Female, Humans, Keratomileusis, Laser In Situ, adverse effects, Riboflavin, Treatment Outcome, Ultraviolet Therapy, methods

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Keratectasia is one of the most severe complications after refractive laser surgery. Usually penetrating keratoplasty is the treatment of choice to achieve an optical rehabilitation in such cases. We report on a female patient who developed keratectasia in both eyes 4 weeks after LASIK. Due to a severe keratectasia 10 months after LASIK, a treatment with riboflavin/UVA cross-linking was performed. Due to the induced collagen cross-linking the biomechanical status of the cornea was stabilized and a progression of the keratectasia was prevented. The postoperative refraction and corneal topography have been stable for 18 months. Collagen cross-linking leads to a stiffening of the anterior parts of the corneal stroma. The increase of biomechanical stability can stop the progression of a keratectasia after LASIK by means of a simple procedure.

          Related collections

          Author and article information

          Comments

          Comment on this article